Literature DB >> 15207939

Worsening of depressive symptoms 6 months after an acute coronary event in older adults is associated with impairment of cardiac autonomic function.

M Soledad Ladrón de Guevara1, Silvina I Schauffele, Leonardo C Nicola-Siri, Rodolfo D Fahrer, Enrique Ortíz-Frágola, José A Martínez-Martínez, Daniel P Cardinali, Salvador M Guinjoan.   

Abstract

BACKGROUND: Depression increases mortality of coronary patients, and autonomic dysfunction has been proposed as an explanation for this association.
METHODS: In a sample of 38 adults > or = 60 years with myocardial infarction or unstable angina, we studied depression (presence of a major depressive episode and 21-item Hamilton depression score) and heart rate variability (HRV) of 550 normal beats shortly after admission to the coronary care unit (CCU). Thirty patients were alive at 6 months and were studied at that time as well. Spectral HRV measurements included power in the high-frequency range (HF, 0.15-0.55 Hz, a measure of parasympathetic activity) and low-frequency range (LF, 0.03-0.15 Hz). Nonspectral HRV measurements included standard deviation of normal beats (SDNN) and two measures of vagal activity: percentage of adjacent cycles differing by >50 ms (pNN50) and the root-mean-square of differences in successive beats (rMSNN).
RESULTS: Patients who died within 6 months (n=8) had a higher Hamilton-D score than survivors (13.9+/-6.5 vs. 18.4+/-5.6, P=0.039) and were more likely to have an episode of major depression upon admission to the CCU (71 vs. 27%, P=0.027). An increase in Hamilton-D score at 6 months correlated with a decrease in total (r=-0.48, P=0.014), high-frequency (r=-0.49, P=0.007), and low-frequency HRV (r=-0.46, P=0.014). LIMITATIONS: Patients belonged to a single institution and there was a small proportion of men.
CONCLUSIONS: Progression of mood symptoms 6 months after an acute coronary event is associated with an impairment of autonomic control of the heart in elderly individuals. Copyright 2003 Elsevier B.V.

Entities:  

Mesh:

Year:  2004        PMID: 15207939     DOI: 10.1016/S0165-0327(03)00105-8

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Respiratory sinus arrhythmia reactivity to a sad film predicts depression symptom improvement and symptomatic trajectory.

Authors:  Vanessa Panaite; Alexandra Cowden Hindash; Lauren M Bylsma; Brent J Small; Kristen Salomon; Jonathan Rottenberg
Journal:  Int J Psychophysiol       Date:  2015-12-08       Impact factor: 2.997

Review 2.  Treatment-resistant depression and mortality after acute coronary syndrome.

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Am J Psychiatry       Date:  2009-03-16       Impact factor: 18.112

3.  Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot study.

Authors:  Michael A Rapp; Nina Rieckmann; David A Lessman; Cheuk Y Tang; Robert Paulino; Matthew M Burg; Karina W Davidson
Journal:  Psychother Psychosom       Date:  2010-02-20       Impact factor: 17.659

Review 4.  Heart rate variability measurement and clinical depression in acute coronary syndrome patients: narrative review of recent literature.

Authors:  Patricia Re Harris; Claire E Sommargren; Phyllis K Stein; Gordon L Fung; Barbara J Drew
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-18       Impact factor: 2.570

5.  Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety.

Authors:  Jessica Klusek; Giuseppe LaFauci; Tatyana Adayev; W Ted Brown; Flora Tassone; Jane E Roberts
Journal:  J Neurodev Disord       Date:  2017-05-02       Impact factor: 4.025

6.  Heart rate variability and incidence of depression during the first six months following first myocardial infarction.

Authors:  Alina Wilkowska; Andrzej Rynkiewicz; Joanna Wdowczyk; Jerzy Landowski; Wiesław Jerzy Cubała
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-10       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.